The effectiveness and safety of Chaiqin Qingning Capsule in upper respiratory tract infections with fever: A prospective, double-blinded, randomized, multicenter controlled trial
Background and aim: Presently, over-the-counter drugs that can treat upper respiratory tract infections (URTI) are rarely effective and safe. Chaiqin Qingning Capsule (CQQNC), a Chinese patent medicine, which has been verified by long-term clinical practice is recommended by Chinese experts for the...
Saved in:
Main Authors: | Xiangru Xu (Author), Wen Zhang (Author), Xinxin Wu (Author), Yuting Sun (Author), Hongqiang Yang (Author), Yuting Pu (Author), Shuang Zhou (Author), Bangjiang Fang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study
by: Wen Zhang, et al.
Published: (2022) -
A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant
by: Changya Liu, et al.
Published: (2023) -
Zhuifeng Tougu capsules in the treatment of knee osteoarthritis (cold dampness obstruction syndrome): a randomized, double blind, multicenter clinical study
by: Longmei Zhao, et al.
Published: (2024) -
Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
by: Weinan Li, et al.
Published: (2023) -
Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Xuan Xu, et al.
Published: (2023)